Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer

NCT04217057 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04217057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04217057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
February 7, 2020
Completion date
February 7, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer